Director, Patent Counsel
Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality by harnessing the power of RNAi for human health as an innovative new class of medicines. We are a growing biopharmaceutical company with two approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.
Headquartered in Cambridge, Mass., Alnylam employs over 1,400 people in 19 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globes Top Places to Work five years in a row (2015-2019), a Great Place to Work in the U.K. and Switzerland in 2020 and Science Magazines #1 Top Employer in 2019. Please visit www.alnylam.com for more information.
Reporting to the Senior Patent Counsel, the Patent Counsel will work in a fast-paced team environment on a broad range of intellectual property matters helping to build and maintain a strong IP portfolio protecting Alnylams drug development efforts. This person will work closely with scientists and management, will possess good business, legal, and scientific sense and have a solid understanding of intellectual property laws and concepts related to the biopharmaceutical business strategies and patents.
Summary of Key Responsibilities
The Patent Counsel will drive the creation of new patent applications to expand Alnylams intellectual property portfolio, including:
- Performing patentability searches and prepare patentability opinions
- Drafting and prosecuting patent applications directed to RNAi therapeutic agents and delivery technologies
- Liaise with external legal counsel
- Educate and advise employees on IP matters
- Conduct freedom-to-operate searches and prepare FTO opinions in support of R&D efforts
- Participate in due diligence with in-house and outside counsel to evaluate IP portfolios
- Support late stage clinical programs
- Provide IP support for marketed products including creating an maintaining Orange Book listings, obtaining all available patent term adjustments and providing general support for regulatory filings around the world.
- MS in biology, chemistry or biochemistry required, PhD preferred
- A JD from an accredited U.S. law school
- Admitted to practice before the U.S. Patent and Trademark Office
- Qualified candidates will have a minimum of 5-7 years of in-house or law firm experience (a mix of in-house and law firm experience is ideal) in the preparation and prosecution of patent applications, preferable with experience in the oligonucleotide therapeutic space
- Familiarity with scientific and IP databases
- Excellent writing, analytical and communication skills
- Organized, independent and detailed oriented
Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment.